The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
Mannitol, Glycerol, Dipotassium glycyrrhizinate, PEG/PPG copolymer, EDTA disodium salt, N-hydroxymethylglycinate, Polysorbate 20, Potassium sorbate, Sodium hydroxide, Purified water, natural flavors.
Osmotically acting medical device with antiedemigen and phlogolitic effects.
NARIVENT is indicated for the:
• reduction of nasal obstruction in patients affected by nasal turbinate hypertrophy and by specific (allergic rhinitis) or non-specific vasomotor rhinitis;
• treatment of oedema associated with acute and chronic rhinosinusal and adenoid inflammatory conditions;
• treatment and prevention of post-surgical relapse of nasal polyps;
• pre- and post-surgical treatment of nasal and rhinosinusal pathologies.
If you have information about any adverse effects or other drug-related problems, please fill in the form